| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Pathology and Molecular Medicine, Intestinal Disease Research Programme, McMaster University, Hamilton, Ontario, Canada
Enterohemorrhagic Escherichia coli O157:H7 (EHEC) is an enteric pathogen that causes potentially fatal symptoms after intimate adhesion, modulation of intestinal epithelial signal transduction, and alteration of epithelial function (eg, barrier disruption). Although the epithelial barrier is critical to gut homeostasis, only a few agents, such as transforming growth factor (TGF)-ß, can enhance or protect epithelial barrier function. Our aims were to delineate the mechanism(s) behind TGF-ß-induced barrier enhancement and to determine whether TGF-ß could prevent EHEC-induced barrier disruption. Using monolayers of the human T84 colonic epithelial cell line, we found that TGF-ß induced a significant increase in transepithelial electrical resistance (a measure of paracellular permeability) through activation of ERK MAPK and SMAD signaling pathways and up-regulation of the tight junction protein claudin-1. Additionally, TGF-ß pretreatment of epithelia blocked the decrease in transepithelial electrical resistance and the increase in transepithelial passage of [3H]-mannitol caused by EHEC infection. EHEC infection was associated with reduced expression of zonula occludens-1, occludin, and claudin-2 (but not claudin-1 or claudin-4); TGF-ß pretreatment prevented these changes. These studies provide insight into EHEC pathogenesis by illustrating the mechanisms underlying TGF-ß-induced epithelial barrier enhancement and identifying TGF-ß as an agent capable of blocking EHEC-induced increases in epithelial permeability via maintenance of claudin-2, occludin, and zonula occludens-1 levels.
This article has been cited by other articles:
 |
|
 |
|
  B. Temmesfeld-Wollbruck, B. Brell, C. zu Dohna, M. Dorenberg, A. C. Hocke, H. Martens, J. Klar, N. Suttorp, and S. Hippenstiel Adrenomedullin reduces intestinal epithelial permeability in vivo and in vitro Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G43 - G51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Carrozzino, P. Pugnale, E. Feraille, and R. Montesano Inhibition of basal p38 or JNK activity enhances epithelial barrier function through differential modulation of claudin expression Am J Physiol Cell Physiol, January 1, 2009; 297(3): C775 - C787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Ewaschuk, H. Diaz, L. Meddings, B. Diederichs, A. Dmytrash, J. Backer, M. Looijer-van Langen, and K. L. Madsen Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G1025 - G1034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Chaturvedi, C. P. Gayer, H. M. Marsh, and M. D. Basson Repetitive deformation activates Src-independent FAK-dependent ERK motogenic signals in human Caco-2 intestinal epithelial cells Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1350 - C1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Handfield, H.V. Baker, and R.J. Lamont Beyond Good and Evil in the Oral Cavity: Insights into Host-Microbe Relationships Derived from Transcriptional Profiling of Gingival Cells Journal of Dental Research, March 1, 2008; 87(3): 203 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Feldman, B. Kiely, N. Martin, G. Ryan, T. McMorrow, and M. P. Ryan Role for TGF-beta in Cyclosporine-Induced Modulation of Renal Epithelial Barrier Function J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1662 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Reardon and D. M. McKay TGF-beta Suppresses IFN-{gamma}-STAT1-Dependent Gene Transcription by Enhancing STAT1-PIAS1 Interactions in Epithelia but Not Monocytes/Macrophages J. Immunol., April 1, 2007; 178(7): 4284 - 4295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Osanai, N. Nishikiori, M. Murata, H. Chiba, T. Kojima, and N. Sawada Cellular Retinoic Acid Bioavailability Determines Epithelial Integrity: Role of Retinoic Acid Receptor {alpha} Agonists in Colitis Mol. Pharmacol., January 1, 2007; 71(1): 250 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Rinker-Schaeffer, J. P. O'Keefe, D. R. Welch, and D. Theodorescu Metastasis Suppressor Proteins: Discovery, Molecular Mechanisms, and Clinical Application. Clin. Cancer Res., July 1, 2006; 12(13): 3882 - 3889. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
